Immunotherapy-Associated Pancreatic Adverse Events: Current Understanding of Their Mechanism, Diagnosis, and Management

Immune checkpoint inhibitors (ICIs) such as anti-programmed death-1 (PD-1) and its ligand PD-L1 and anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibodies, are involved in T cell-mediated immune response augmentation and promote anti-tumor immunity. Cancer patients treated with combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ya, Zhang, Hao, Zhou, Li, Li, Weichun, Yang, Le, Li, Wen, Li, Kezhou, Liu, Xubao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959713/
https://www.ncbi.nlm.nih.gov/pubmed/33732647
http://dx.doi.org/10.3389/fonc.2021.627612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959713/
https://www.ncbi.nlm.nih.gov/pubmed/33732647
http://dx.doi.org/10.3389/fonc.2021.627612

Ejemplares similares